Wormex

Quick links to important sections

Wormex

Method of action: Anthelmintic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Wormex

Quick Facts

Property Description
Active ingredient Oxantel, Praziquantel, Pyrantel
Form Solid oral preparation (e.g., tablet)
Pharmacological class Broad-spectrum anthelmintic
Common use Antiparasitic (Elimination of parasitic worms)
Origin Synthetic

Wormex is a specific combination product classified as a broad-spectrum anthelmintic, a pharmaceutical category dedicated to eliminating parasitic worms from the body. This synthetic medicine is intentionally designed to address a wide range of helminthic infections through its unique triple-agent composition. Pyrantel, one of the core active ingredients, is recognized on the Model List of Essential Medicines as an established treatment for certain parasitic infestations.

Composition and Physical Form of Wormex

The core identity of Wormex is defined by its three active ingredients: Oxantel, Praziquantel, and Pyrantel. This medication is presented as a solid oral preparation, typically a tablet, intended for oral administration. The inclusion of Praziquantel, a pyrazinoisoquinoline derivative, is crucial for expanding the drug's action to flatworms, differentiating it from purely anti-roundworm agents. Its inclusion provides coverage for multiple parasite types. Oxantel, a distinct analogue of Pyrantel, complements the formulation by extending efficacy to species like whipworm, which may be less susceptible to Pyrantel alone.

Why a Combination of Oxantel, Praziquantel, and Pyrantel?

The strategic use of Oxantel, Praziquantel, and Pyrantel ensures that the product simultaneously targets nematodes (roundworms/hookworms) and cestodes/trematodes (tapeworms/flukes). This intentional design, leveraging three distinct physiological effects—primarily causing paralysis and structural damage in the parasites—provides efficient removal of the parasitic entities. The main benefit is the comprehensive, coordinated action against the wide variety of intestinal worms that can cause helminthic infections, a typical use scenario when clinicians suspect a mixed parasitic load. This approach is intended to maximize the probability of successful eradication from the body compared to monotherapy.

Regulatory References

  1. WHO Essential Medicines List
  2. NIH DailyMed on Praziquantel

What side effects are possible with Wormex?

Possible Side Effects and Safety Information

The safety profile for Wormex, which contains Oxantel, Praziquantel, and Pyrantel, is documented through official regulatory classification of observed adverse reactions. Side effects are categorized primarily by frequency and the body system affected, according to standards set by regulatory authorities such as the FDA and EMA.

Adverse Reaction Classification

Adverse events classified as Common (affecting up to 1 in 10 patients) typically involve the Gastrointestinal System and the Nervous System. These may include headache, dizziness, nausea, vomiting, and abdominal discomfort. Systemic reactions such as general malaise or pyrexia (fever) are also cited within the common or very common frequency bands documented for the active components.

Rarely observed reactions may involve the Skin and Subcutaneous Tissue (such as urticaria or rash) or transient changes in the Hepato-biliary System, such as increases in liver enzymes.

Serious Adverse Reactions and Safety Constraints

The official labeling notes that serious adverse events are rare. Documented Serious Adverse Reactions involve the Cardiac System (including arrhythmias like ventricular fibrillation or AV blocks) and the potential for severe systemic hypersensitivity reactions. The regulatory profile also notes the potential for a severe inflammatory reaction in patients treated during the acute phase of certain parasitic infections.

Specific Safety Constraints are documented in the official labeling. Use is constrained in patients with ocular cysticercosis due to the risk of irreversible lesions. Additionally, patients with severe hepatic impairment may experience considerably higher plasma concentrations of the active ingredients. For lactating women, official safety statements advise a temporary cessation of nursing after administration, a period explicitly defined in regulatory documents.

Overdose and Emergency Response

The official regulatory profile for Wormex (Oxantel, Praziquantel, Pyrantel) details the documented manifestations and mandatory actions in the event of an overdose. Signs may range from common gastrointestinal symptoms, including nausea, vomiting, abdominal pain, and diarrhea, to more pronounced systemic and neurological effects such as headache, dizziness, somnolence, and general malaise.

Severe or life-threatening outcomes are specifically documented in regulatory labeling. These include the potential for serious cardiac arrhythmias, such as ventricular fibrillation and Atrioventricular (AV) blocks. Central Nervous System (CNS) involvement may also occur, manifesting as seizures or convulsions, which often requires mandated hospitalization for observation and monitoring.

In the event of a suspected overdose, regulatory authorities state that immediate medical attention must be sought. Users are explicitly instructed to call the Poison Control helpline for guidance. Management is strictly described as symptomatic and supportive, as no specific antidote is known. Officially described supportive procedures may include the administration of a fast-acting laxative. Monitoring requirements exist for severe symptoms and for populations with specific risks, such as those with underlying hepatic impairment or decreased renal function.

Therapeutic Uses of Wormex

The medication is commonly used to help with conditions presenting with acute episodes of parasitic infections. The core active ingredients are utilized for a range of human infections and are considered relevant for their comprehensive therapeutic domain.

This product is applied across domains where additional symptomatic support is needed for a wide range of parasitic worms, including roundworms, tapeworms, and flukes. It is commonly used in clinical settings that involve mass drug administration or household-level management, and is relevant for easing symptoms that may interfere with daily functioning.

“It contributes to easing the overall symptom load and supports the patient during difficult episodes by easing distress.”

Wormex is relevant for easing symptoms related to systemic imbalance, which may include chronic diarrhea, abdominal discomfort, and nutritional deficiencies (like weight loss). It helps address symptom clusters in vulnerable groups, such as children in endemic areas.


Quick Fact: Support for Symptoms Related to Digestive Discomfort The treatment assists with maintaining functional stability and is primarily relevant for easing symptoms related to persistent gastrointestinal and nutritional strain that are part of the overall symptomatic burden.

Eligibility and Restrictions for Use

Population Eligibility Status

Wormex is approved for use in adults and children 2 years of age and older. Regulatory safety and effectiveness have not been established for use in children younger than two years. Official labeling notes that greater sensitivity in older adults cannot be ruled out.


Absolute Contraindications

Wormex must not be used by individuals with a known hypersensitivity to any of its active components. It is strictly contraindicated in patients diagnosed with ocular cysticercosis due to the risk of irreversible eye damage. Furthermore, concomitant use with the strong CYP450 inducer Rifampin is prohibited, as it can lead to sub-therapeutic drug levels.


Conditional Use and Restrictions

Use is restricted and requires caution in patients with moderate to severe hepatic impairment (Child-Pugh Class B or C) because of the potential for increased drug concentrations. Caution is also warranted for patients with a history of epilepsy or seizures. For pregnant women, use is restricted to only if clearly needed. Nursing mothers are advised to not breastfeed during treatment and for a period of 72 hours afterward.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation establishes specific interaction patterns for the components of Wormex (Oxantel, Praziquantel, Pyrantel), primarily concerning pharmacokinetic changes and pharmacodynamic conflicts.

Documented Pharmacokinetic Interactions

Interactions affecting plasma concentrations of Praziquantel are common and are rooted in hepatic enzyme modulation. Co-administration with strong Cytochrome P450 (CYP) enzyme inducers, such as Rifampin, is formally prohibited due to a severe reduction in Praziquantel exposure. Other CYP inducers like Phenytoin, Phenobarbital, and Carbamazepine also reduce plasma levels. Conversely, CYP inhibitors such as Cimetidine and Itraconazole may increase Praziquantel plasma concentrations.

Consumption of Grapefruit Juice is also documented to increase the plasma exposure of Praziquantel.

Interaction-Related Restrictions and Conditions

Restriction Type Interacting Substance Regulatory Basis
Formal Contraindication Rifampin Lack of therapeutic plasma levels
Pharmacodynamic Conflict Piperazine Loss of anthelmintic efficacy
Mandatory Timing Rule Rifampin Must be discontinued four weeks before administration

The combination of Pyrantel with Piperazine is explicitly restricted due to a documented pharmacodynamic antagonism that may counteract the intended therapeutic effect. Additionally, regulatory information notes that interactions resulting in increased plasma concentrations are heightened in patients with Moderate to Severe Hepatic Impairment, a population-specific consideration due to reduced drug clearance.

Mechanism of Action

How Wormex Works

The pharmacological action of Wormex is achieved through a coordinated, triple-agent mechanism targeting two distinct physiological systems essential for parasite survival: neuromuscular coordination and structural integrity.


Dual-Action Parasite Neuromuscular Blockade

This domain encompasses the effects of Pyrantel and Oxantel, which function as specific agonists at distinct subtypes ( L-subtype and N-subtype) of parasitic nicotinic acetylcholine receptors ( nAChRs) in nematodes. This targeted interaction induces sustained postsynaptic depolarization and uncontrolled muscle stimulation, resulting in profound spastic paralysis. This paralysis prevents the worms from maintaining attachment and resisting host peristalsis, leading to their subsequent physical clearance.


Rapid Ion Flux and Structural Disruption

The mechanism of Praziquantel is distinct, focusing on cestodes and trematodes by disrupting Ca^2+ ion homeostasis. It rapidly increases the permeability of the parasite's cell membrane, causing a massive, uncontrolled calcium influx. This influx simultaneously triggers intense muscle spasms (tetany) and rapid structural disintegration of the protective outer layer (tegument). This dual effect of functional spasm and structural breakdown subjects the parasite to the host environment and leads to its functional compromise.

Dosage and Administration Information

How to Use Wormex: Administration Guidelines

This section describes the general principles for the administration of the triple combination product (Oxantel, Praziquantel, Pyrantel), reflecting standardized practices for these active ingredients.


Administration Scope

The medicine is designed exclusively for oral administration as a solid preparation. Dosing is calculated as a weight-based regimen (milligrams per kilogram of body weight), a principle established for anthelmintics to ensure effective eradication. The tablet is often manufactured with a score line to facilitate the precise splitting necessary for accurate weight-based dosing.


Dosing Schedule and Context

Treatment follows an infrequent, short-term course, most commonly a single day of dosing. For certain severe or mixed infections, the total daily dose may be prescribed as divided doses administered three times over that single day, separated by specific time intervals. Administration must occur with water during a meal to optimize drug absorption and minimize potential gastrointestinal intolerance.


Population-Specific Procedures

Pediatric administration requires special procedural attention to ensure the prescribed dose is delivered. Procedural guidelines indicate that for younger children, the scored tablet may be crushed or segmented and then mixed with liquid or semi-solid food. Any portion of the dose prepared in this way must be consumed within one hour of mixing to maintain dose integrity. A separate, single repeat dose may be scheduled after a 2–3 week interval for certain parasitic infections to address potential life-cycle recurrence. These instructions define the standardized usage protocol.

Recent Clinical Evidence

Wormex: Recent Clinical Evidence

Overview of Efficacy and Tolerability

Clinical research exploring the use of Wormex primarily consists of Phase 3 randomized controlled trials (RCTs) involving adult and school-aged child populations with confirmed parasitic infections, such as hookworm. Studies examined whether the treatment was associated with a change in the severity of symptoms and evaluated outcomes based on the Cure Rate (CR)—the percentage of participants who become egg-negative post-treatment—and the Egg Reduction Rate (ERR). Findings have indicated differences in ERR and CR based on the type of parasite being treated.

Study Outcomes and Comparisons

Research explored the effectiveness of different treatment regimens against soil-transmitted helminths (STH). Trials comparing a single-dose regimen to a multiple-dose regimen (e.g., 100 mg twice daily for three days) reported that differences were observed in measures of disease clearance. For infections like hookworm, the multiple-dose regimen has been associated with a significantly higher CR in study populations when compared to the single-dose approach, though the single dose may be effective for Ascaris lumbricoides.

Combination Therapy

Studies have explored whether adding Wormex to other anti-parasitic drug regimens was associated with changes in long-term outcomes, particularly in areas with known drug resistance or persistent high infection rates. The use of multiple drugs with different mechanisms of action is a strategy evaluated in research to address potential resistance and may be associated with improved overall efficacy in trial settings.

Tolerability

Studies focused on the assessment of tolerability in adult and pediatric participants. The most commonly reported events in trials were generally mild, including abdominal pain, headache, and diarrhea. Research suggested that individuals with known liver impairment were often excluded from the study protocols, focusing the assessment of tolerability on otherwise healthy participants.

Frequently Asked Questions (FAQ)

Common questions about Wormex (FAQ)


Q: How quickly does Wormex start to work?

The drug is designed to act rapidly. Official pharmacokinetic data shows that Praziquantel, one of the active agents, is quickly absorbed and reaches its peak concentration in the bloodstream within approximately 2 to 2.6 hours. Pyrantel, another agent, acts locally on the parasites in the gut and is poorly absorbed.


Q: Does Wormex continue to work after I stop taking it?

The active ingredients are rapidly eliminated from the body after the administration course is complete. Praziquantel has a short half-life, meaning the plasma concentration significantly drops in a matter of hours. The drug's primary action is generally confined to the short treatment period. Official information indicates that a separate, single repeat administration may be considered after a few weeks to target potential parasite life-cycle recurrence.


Q: Is Wormex safe for people who are elderly?

Official documentation indicates that greater sensitivity in older adults cannot be entirely ruled out. Official prescribing information notes that increased caution may be applied when this medicine is used in older adults.


Q: Does alcohol change the way Wormex works in the body?

Yes, official safety information indicates that consumption of alcohol is restricted when taking this medicine. Regulatory information suggests that combining alcohol with the drug may increase the risk of certain side effects, such as dizziness or feeling faint.


Q: Does Wormex have any impact on mental alertness or driving?

Yes, official safety documentation notes that this medicine may cause common side effects like drowsiness and dizziness, which can reduce mental alertness. Official labeling states that because these effects may occur, tasks requiring mental alertness, such as driving or operating heavy machinery, should be avoided on the day of treatment and for 24 hours following the last dose.


Q: Do you have to avoid certain foods while using Wormex?

Yes, official product information indicates that consumption of grapefruit or grapefruit juice is restricted. This restriction is due to the potential for grapefruit to increase the concentration of one of the active ingredients in the blood (plasma exposure).


Q: How long does Wormex stay in your system after the last dose?

The active ingredients are cleared relatively quickly. Pharmacokinetic data indicates that one of the main components is largely eliminated from the plasma within approximately 12 hours after the final dose. The other main component acts locally in the intestines and is mostly excreted unchanged.


Q: Can people with kidney problems use Wormex?

Official documentation notes that increased caution may be applied for individuals with existing kidney disease. Regulatory information suggests that slower drug removal from the body in patients with kidney impairment could increase the effects of the medicine.


Q: Why does the packaging for Wormex mention liver function tests?

The medicine is metabolized (broken down) in the liver. For individuals with moderate to severe liver impairment, the drug's elimination may be slowed, potentially leading to increased levels in the body. Official documentation advises caution and notes that monitoring of liver function may be indicated in these circumstances.


Q: Is Wormex available over-the-counter in some countries?

One of the components, Pyrantel Pamoate, is classified as an over-the-counter (OTC) drug and is available without a prescription in some countries. However, the regulatory status and availability of the full triple-agent combination product can vary significantly depending on the country or region.


Q: Why do some users report a metallic taste after taking Wormex?

Official product information notes that the tablets have a distinct bitter taste. If the tablet is not swallowed quickly and is held in the mouth, this bitter taste may cause gagging or vomiting.


Q: What if I vomit shortly after taking a dose of Wormex?

If vomiting occurs shortly after administration, consulting a healthcare professional is generally indicated. They would determine if re-dosing is necessary based on the timing and the amount of medicine retained.


Q: Can Wormex be taken if I have a history of heart issues?

Official labeling notes that increased caution is applied for individuals with a history of heart rhythm problems. Regulatory safety information indicates that the medicine may worsen or cause changes to existing heart rhythm conditions.


Q: Is it true that taking Wormex requires monitoring by a healthcare provider?

Yes, clinical monitoring by a healthcare provider is generally indicated during treatment. This is particularly important for patients with specific pre-existing conditions, such as liver or heart rhythm issues, to ensure appropriate management.


Q: Are there any religious or dietary restrictions that conflict with Wormex?

The primary known restriction listed in regulatory documents is the avoidance of grapefruit and grapefruit juice due to its effect on drug levels. Religious restrictions are not noted in the official regulatory documentation.


Q: Does Wormex cause weight gain or weight loss?

According to data from clinical trials, weight loss is listed as an adverse reaction of unknown incidence. Weight gain is not cited in the official adverse reaction profile.


Q: What is the purpose of the inactive ingredients in the Wormex pill?

Inactive ingredients, such as stabilizers, flavorings, and preservatives, are included in the medicine to aid in the stability of the product. These components also help with the physical formulation, taste, and overall presentation of the pill.

How should Wormex be stored and disposed of?

How to Store and Dispose of Wormex (Oxantel, Praziquantel, Pyrantel)

This section outlines the mandatory storage and disposal instructions for Wormex (a solid oral anthelmintic combination) as stated in official regulatory documents, ensuring its stability and safe handling.

Required Storage and Stability

Wormex must be stored at Controlled Room Temperature, typically below 30 C (86 F), and must be protected from both light and moisture. The medicine should be kept in its original container or carton, and the bottle or blister pack must remain tightly closed to maintain product integrity. Specific stability rules apply to retained partial doses; for example, halved tablets may have a limited shelf-life of one month and must be stored correctly.

Handling and Disposal

It is officially required to KEEP OUT OF REACH OF CHILDREN. For disposal, unused or expired Wormex must not be released into the environment (e.g., wastewater or household trash). You must consult a healthcare professional or local authority to dispose of the product in accordance with local or national regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Wormex found in:

A-Z Index: